Azenta Beheer

Beheer criteriumcontroles 0/4

De CEO Azenta is John P. Marotta, benoemd in Sep2024, heeft een ambtstermijn van minder dan een jaar. bezit rechtstreeks 0.031% van de aandelen van het bedrijf, ter waarde $ 630.76K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1.8 jaar en 0.8 jaar.

Belangrijke informatie

John P. Marotta

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	less than a year
Eigendom CEO	0.03%
Management gemiddelde ambtstermijn	1.8yrs
Gemiddelde ambtstermijn bestuur	less than a year

Recente managementupdates

Recent updates

Analysts Have Just Cut Their Azenta, Inc. (NASDAQ:AZTA) Revenue Estimates By 14%

Nov 17

CEO

John P. Marotta (43 yo)

less than a year

Tenure

Mr. John P. Marotta is President & CEO of Azenta, Inc. from September 9, 2024. Mr. Marotta serves as Executive in Residence at Patient Square Capital, LP since joining the firm in March 16, 2023. He levera...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Jason Joseph	Senior VP	13.7yrs	US$1.44m	0.25% $ 5.1m
John P. Marotta	President & CEO	less than a year	geen gegevens	0.031% $ 630.8k
Lawrence Lin	Executive VP & CFO	no data	geen gegevens	geen gegevens
Violetta Hughes	VP & Chief Accounting Officer	1.3yrs	geen gegevens	0.0010% $ 20.8k
Michael Paulo	VP and Chief Information & Digital Officer	7.3yrs	geen gegevens	geen gegevens
Yvonne Perron	Vice President of Financial Planning & Analysis and Investor Relations	no data	geen gegevens	geen gegevens
John O'Brien	Senior Vice President of Corporate Development	14.5yrs	geen gegevens	geen gegevens
Olga Pirogova	Senior VP & Chief HR Officer	1.3yrs	geen gegevens	0.0024% $ 48.4k
J. Woodward	Senior Vice President of Global Quality & Regulatory	15yrs	geen gegevens	geen gegevens
Ginger Zhou	Senior VP and GM of the Genewiz Multiomics & Synthesis Solutions	5.5yrs	geen gegevens	0.021% $ 434.0k
David Wang	Senior VP & GM of Sample Management Solutions	1.8yrs	geen gegevens	0.014% $ 289.1k
Herman Cueto	Employee Advisor	no data	geen gegevens	0.0066% $ 134.8k

1.8yrs

Gemiddelde duur

50yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van AZTA wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.8 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Tina Nova	Independent Director	1.8yrs	US$207.50k	0.013% $ 274.1k
Michael Rosenblatt	Independent Director	6.2yrs	US$260.00k	0.029% $ 589.0k
Martin Madaus	Independent Director	less than a year	geen gegevens	0.016% $ 334.4k
Didier Hirsch	Independent Director	less than a year	geen gegevens	0.0076% $ 156.4k
Alan Malus	Independent Director	no data	geen gegevens	0.0022% $ 44.9k
Edward Bousa	Independent Director	less than a year	geen gegevens	0.0054% $ 111.3k
Robyn Davis	Independent Vice Chair of the Board	11.4yrs	US$278.75k	0.065% $ 1.3m
William Cornog	Independent Director	no data	geen gegevens	0.032% $ 666.4k
Erica McLaughlin	Independent Director	4.6yrs	US$273.75k	0.028% $ 578.9k
Frank Casal	Independent Chairman	3yrs	US$275.00k	0.021% $ 424.1k
Quentin Koffey	Independent Director	no data	geen gegevens	0.0022% $ 44.9k

0.8yrs

Gemiddelde duur

64yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van AZTA wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 0.8 jaar), wat duidt op een nieuw bestuur.

Azenta Beheer

Beheer criteriumcontroles 0/4

Belangrijke informatie

Recente managementupdates

Independent Director recently bought US$495k worth of stock

Azenta, Inc. Announces Chief Financial Officer Changes

Azenta, Inc. Announces Management Changes

Stephen Schwartz to Retire as CEO of Azenta, Inc

Senior VP notifies of intention to sell stock

High number of new directors

Recent updates

Independent Director recently bought US$495k worth of stock

Consensus revenue estimates decrease by 14%

Analysts Have Just Cut Their Azenta, Inc. (NASDAQ:AZTA) Revenue Estimates By 14%

Price target decreased by 7.2% to US$56.60

Shareholders Should Be Pleased With Azenta, Inc.'s (NASDAQ:AZTA) Price

Full year 2024 earnings: EPS misses analyst expectations

Azenta, Inc. Announces Chief Financial Officer Changes

Azenta, Inc. to Report Q4, 2024 Results on Nov 12, 2024

Azenta, Inc Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test

Azenta: Life Science Play Is Not Coming To Life

Azenta, Inc. Announces Management Changes

Price target decreased by 7.2% to US$58.25

Consensus EPS estimates fall by 29%

Forecast to breakeven in 2026

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

No longer forecast to breakeven

Azenta, Inc. to Report Q3, 2024 Results on Aug 06, 2024

Azenta, Inc.'s (NASDAQ:AZTA) Shares May Have Run Too Fast Too Soon

Azenta, Inc. Provides Earnings Guidance for the Full Fiscal Year 2024

Stephen Schwartz to Retire as CEO of Azenta, Inc

Azenta, Inc. to Report Q2, 2024 Results on May 08, 2024

Should You Investigate Azenta, Inc. (NASDAQ:AZTA) At US$52.18?

Now 20% overvalued

Shareholders Should Be Pleased With Azenta, Inc.'s (NASDAQ:AZTA) Price

Consensus EPS estimates fall by 20%

New major risk - Revenue and earnings growth

Senior VP notifies of intention to sell stock

Consensus EPS estimates fall by 19%

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

High number of new directors

Azenta, Inc. Announces the Launch of the BioArc Ultra

Price target increased by 9.9% to US$72.00

Azenta, Inc. to Report Q1, 2024 Results on Feb 07, 2024

Azenta, Inc. Provides Earnings Guidance for the Fiscal Year 2024

Ellen M. Zane Decides Not to Stand for Election to the Board of Directors of Azenta, Inc

Subdued Growth No Barrier To Azenta, Inc.'s (NASDAQ:AZTA) Price

Azenta, Inc., Annual General Meeting, Jan 30, 2024

Key Executive notifies of intention to sell stock

Consensus EPS estimates fall by 14%

Consensus EPS estimates fall by 20%

Azenta, Inc. Provides Earnings Guidance for the Full Year Fiscal 2024

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Azenta, Inc. to Report Q4, 2023 Results on Nov 13, 2023

Is There An Opportunity With Azenta, Inc.'s (NASDAQ:AZTA) 31% Undervaluation?

Politan Capital Provides Information to the Shareholders

Consensus EPS estimates upgraded to US$0.39 loss

Azenta, Inc. Announces Chief Financial Officer Changes, Effective October 16, 2023

Politan Capital Management Engages in Discussions with Azenta

Politan Capital Management Engages in Discussions with Azenta

At US$50.66, Is It Time To Put Azenta, Inc. (NASDAQ:AZTA) On Your Watch List?

Now 23% undervalued

New minor risk - Insider selling

Insider recently sold US$407k worth of stock

Independent Director notifies of intention to sell stock

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Azenta, Inc. Revises Revenue Guidance for the Full Year of 2023

Estimating The Fair Value Of Azenta, Inc. (NASDAQ:AZTA)

Consensus EPS estimates upgraded to US$0.49 loss

Azenta, Inc. to Report Q3, 2023 Results on Aug 08, 2023

Now 20% undervalued

Independent Chairman notifies of intention to sell stock

Is Azenta, Inc. (NASDAQ:AZTA) Potentially Undervalued?

Price target decreased by 13% to US$52.50

Forecast breakeven date pushed back to 2025

Consensus revenue estimates decrease by 11%

Revenue Downgrade: Here's What Analysts Forecast For Azenta, Inc. (NASDAQ:AZTA)

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Azenta, Inc. Provides Earnings Guidance for the Third Quarter of Fiscal Year 2023

Azenta, Inc. to Report Q2, 2023 Results on May 09, 2023